Aspirin in Patients With Myocardial Infarction and Thrombocytopenia
Status:
Terminated
Trial end date:
2008-02-01
Target enrollment:
Participant gender:
Summary
Primary Objective:
To determine the risk of bleeding from ASA therapy in thrombocytopenic patients who develop
Acute Coronary Syndrome (ACS), and assess its effect on the overall morbidity and mortality
in these patients as well as platelet functions.